Ceribell (CBLL) EBIT (QoQ) (2023 - 2026)
Ceribell (CBLL) EBIT (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Ceribell | 937.87 Mn | 808.61 Mn | 25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.68% |
| Mar 31, 2026 | -42.13% |
| Dec 31, 2025 | 0.35% |
| Sep 30, 2025 | 2.04% |
| Jun 30, 2025 | -5.24% |
| Mar 31, 2025 | -10.27% |
| Dec 31, 2024 | -29.66% |
| Sep 30, 2024 | -17.81% |
| Jun 30, 2024 | 0.21% |
| Mar 31, 2024 | -0.86% |
| Dec 31, 2023 | -16.99% |